Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000714112 | SCV000704739 | uncertain significance | not provided | 2017-09-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000643405 | SCV000765092 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000714112 | SCV000844787 | uncertain significance | not provided | 2023-06-27 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene (http://gnomad.broadinstitute.org). Computational tools predict that this variant is not damaging. |
Gene |
RCV000714112 | SCV000981149 | likely benign | not provided | 2018-05-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Revvity Omics, |
RCV000714112 | SCV003820191 | uncertain significance | not provided | 2020-11-08 | criteria provided, single submitter | clinical testing |